Cited by 23Medicinal Plants and NeuroprotectionNeurological Disease Mechanisms and TreatmentsCholinesterase and Neurodegenerative Diseases

The nootropic and anticholinesterase activities of Clitoria ternatea Linn. root extract: Potential treatment for cognitive decline

Damodaran, Thenmoly, Cheah, Pike See, Murugaiyah, Vikneswaran, Hassan, Zurina·2020·Neurochemistry International

Abstract

Background Clitoria ternatea (CT) is an herbal plant that has been used as a memory booster in folk medicine. CT root extract has been proven to restore chronic cerebral hypoperfusion (CCH)-induced memory deficits in a rat model, but the underlying mechanisms and the toxicity profile following repeated exposure have yet to be explored.The aim of the study To investigate the effects of the chronic (28 days) oral administration of CT root extract on CCH-induced cognitive impairment, neuronal damage and cholinergic deficit, and its toxicity profile in the CCH rat model.Materials and methods The permanent bilateral occlusion of common carotid arteries (PBOCCA) surgery method was employed to develop a CCH model in male Sprague Dawley (SD) rats. Then, these rats were given oral administration of CT root extract at doses of 100, 200, and 300 mg/kg, respectively for 28 days and subjected to behavioural tests. At the end of the experiment, the brain was harvested for histological analysis and cholinesterase activities. Then, blood samples were collected and organs such as liver, kidney, lung, heart, and spleen were procured for toxicity assessment.Results Chronic treatment of CT root extract at doses of 200 and 300 mg/kg, restored memory impairments induced by CCH. CT root extract was also found to diminish CCH-induced neuronal damage in the CA1 region of the hippocampus. High dose (300 mg/kg) of the CT root extract was significantly inhibited the increased acetylcholinesterase (AChE) activity in the frontal cortex and hippocampus of the PBOCCA rats. In toxicity study, repeated doses of CT root extract were found to be safe in PBOCCA rats after 28 days of treatment.Conclusions Our findings provided scientific evidence supporting the therapeutic potential of CT root extract in the treatment of vascular dementia (VaD)-related cholinergic abnormalities and subsequent cognitive decline.

Integrity signals

Registry

Crossref · 10.1016/j.neuint.2020.104785

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 49 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Damodaran, T., Cheah, P. S., Murugaiyah, V., & Hassan, Z.
Affiliations
  • Universiti Sains Malaysia (MY)
  • Universiti Putra Malaysia (MY)
Corresponding author
Hassan, Zurina
Venue
Neurochemistry International
Publisher
Elsevier BV
Published
2020-10
Volume
139
Pages
104785
ISSN
0197-0186 (ISSN-L)
OpenAlex
W3040746977
Cited by
23
References
49
Citations by year
2026: 5 · 2025: 4 · 2024: 5 · 2023: 5 · 2022: 2 · 2021: 1 · 2020: 1
FWCI
2.49
Type
journal article
Language
en
Open access
closed
Locations
  • Neurochemistry International (publishedVersion)
  • PubMed (publishedVersion)
Funders
Universiti Sains Malaysia (1001/CDADAH/8012302)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Pharmacology › Cholinesterase and Neurodegenerative Diseases
Keywords
Clitoria ternatea, root extract, nootropic activity, acetylcholinesterase inhibition, anticholinesterase activity, cognitive decline, vascular dementia, chronic cerebral hypoperfusion, memory impairment, cholinergic deficit, neuroprotection, repeated-dose toxicity, herbal medicine
MeSH terms
Animals, Brain, Cerebrovascular Circulation, Cholinesterase Inhibitors, Male, Plant Extracts, Treatment Outcome, Rats, Sprague-Dawley, Oxidative Stress, Plant Roots, Nootropic Agents, Maze Learning, Clitoria, Rats, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review